• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cost-benefit analysis of immune checkpoint inhibitors: Is the price worth their value?

作者信息

Merchant Yash P, Mehta Vini, Aaqib Shamim Muhammad, Shah Ankit, Shetty Rathan

机构信息

Consultant Head and Neck Oncosurgeon, Department of Oral and Maxillofacial Surgery, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.

Department of Public Health Dentistry, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.

出版信息

Oral Oncol. 2023 Nov;146:106560. doi: 10.1016/j.oraloncology.2023.106560. Epub 2023 Aug 24.

DOI:10.1016/j.oraloncology.2023.106560
PMID:37633200
Abstract
摘要

相似文献

1
Cost-benefit analysis of immune checkpoint inhibitors: Is the price worth their value?免疫检查点抑制剂的成本效益分析：其价格是否物有所值？
Oral Oncol. 2023 Nov;146:106560. doi: 10.1016/j.oraloncology.2023.106560. Epub 2023 Aug 24.
2
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer.评估癌症免疫检查点抑制剂治疗的临床实用性和经济价值所面临的挑战。
J Immunother Cancer. 2019 Sep 3;7(1):235. doi: 10.1186/s40425-019-0707-9.
3
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.度伐利尤单抗巩固治疗与放化疗后不巩固治疗用于意大利国家卫生服务体系中 III 期非小细胞肺癌的成本效果和净货币收益。
Clin Ther. 2020 May;42(5):830-847. doi: 10.1016/j.clinthera.2020.03.012. Epub 2020 Apr 27.
4
Effect of immune checkpoint inhibitors on asthma.免疫检查点抑制剂对哮喘的影响。
Ann Allergy Asthma Immunol. 2022 Aug;129(2):257-258. doi: 10.1016/j.anai.2022.05.019. Epub 2022 May 24.
5
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm.PD-1/PD-L1 轴免疫检查点抑制剂在非小细胞肺癌中的应用：新型治疗模式中的前景、争议和不确定性。
Scand J Clin Lab Invest. 2020 Sep;80(5):360-369. doi: 10.1080/00365513.2020.1742369. Epub 2020 Apr 2.
6
[Immune checkpoint inhibitors in the treatment of progressive multifocal leukoencephalopathy].免疫检查点抑制剂在进行性多灶性白质脑病治疗中的应用
Nervenarzt. 2022 Jun;93(6):624-628. doi: 10.1007/s00115-021-01194-x. Epub 2021 Sep 29.
7
A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy.免疫检查点抑制剂治疗心脏并发症的生物标志物缺失
Intern Med. 2021 Feb 1;60(3):325-326. doi: 10.2169/internalmedicine.5962-20. Epub 2020 Sep 19.
8
The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC.PD-L1 检测对 NSCLC 二线治疗中免疫检查点抑制剂的成本效益和经济影响的影响。
Ann Oncol. 2017 Sep 1;28(9):2256-2263. doi: 10.1093/annonc/mdx305.
9
Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside.解析免疫检查点抑制剂相关自身免疫性糖尿病：从基础到临床。
Front Endocrinol (Lausanne). 2021 Nov 5;12:764138. doi: 10.3389/fendo.2021.764138. eCollection 2021.
10
Fighting ageing with immune checkpoint blockade.用免疫检查点阻断疗法对抗衰老。
Nat Rev Drug Discov. 2023 Jan;22(1):17. doi: 10.1038/d41573-022-00194-z.

引用本文的文献

1
Immune checkpoint blockade for cancer therapy: current progress and perspectives.用于癌症治疗的免疫检查点阻断：当前进展与展望。
J Zhejiang Univ Sci B. 2025 Mar 13;26(3):203-226. doi: 10.1631/jzus.B2300492.
2
Neoadjuvant immunochemotherapy in locally advanced laryngeal cancer and hypopharyngeal cancer: higher objective response rate and organ-preservation rate.局部晚期喉癌和下咽癌的新辅助免疫化疗：更高的客观缓解率和器官保留率。
Invest New Drugs. 2024 Dec;42(6):694-702. doi: 10.1007/s10637-024-01456-w. Epub 2024 Nov 28.